Furthermore, it was also proved to be the strongest predictive factor of disease-free survival and overall survival in patients with primary breast cancer and no axillary lymph node involvement in numerous studies.7,8,11,15,41,42 In our study, 154 patients (40%) had a high uPA level and no axillary lymph node involvement. This evidence concerns the gene PLAU and breast carcinoma.